Head fat is a novel method of measuring metabolic disorder in Chinese obese patients

Lipids in Health and Disease

Shen Qu¹  Le Bu²  Hang Sun²  Yue-ye Huang²  Huan Liu¹  Xing-chun Wang¹ 

[1] Department of Clinical Medicine, Nanjing Medical University, Nanjing, China;Department of Endocrinology and Metabolism, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China

关键词: Hyperuricemia;    Lipid profile;    Regional fat;    Head fat;    Obesity;   

Others  :  1159980
DOI  :  10.1186/1476-511X-13-113

 received in 2014-05-13, accepted in 2014-07-08,  发布年份 2014

【 摘 要 】

Background

Body adiposity, especially ectopic fat accumulation, has a range of metabolic and cardiovascular effects. The aim of this study was to investigate the association between head fat and metabolic values in Chinese obese patients.

Methods

Data of this cross-sectional study from 66 obese patients were collected. Fat distribution was measured by dual-energy X-ray absorptiometry, and data of body weight, body mass index (BMI), neck circumference (NC), waist circumference (WC), hip circumference (HC), visceral index, basal metabolism (BM), glucose metabolism, lipid levels, uric acid (UA) had been collected.

Results

1) Head fat was significantly associated with BMI, WC, HC, visceral index, BM, total fat and total fat excluding head fat in both males and females (p < 0.05). Head fat was positively correlated with upper limb fat, trunk fat, weight, fasting plasma C peptide, fasting plasma insulin and UA in women(p < 0.05), and the association was not statistically significant in male (p > 0.05). Head fat was positively corrected with NC in males (p < 0.05) but not females (p > 0.05). There was no significant correlation between head fat and fasting plasma glucose, total choleslerolemia, triglyceridemia, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and free fat acid in either gender (p > 0.05). 2) Receiver operating characteristic analysis showed that a head fat of 1925.6 g and a head fat of 1567.85 g were the best cut-off values to determine subjects with low high-density lipoprotein cholesterol and hyperuricemia respectively.

Conclusions

Head fat accumulation was closely associated with increased body fat, hyperinsulinemia, hyperuricemia, and impared lipid profile, suggesting it might be used as an indicator for dyslipidemia and hyperuricemia.

【 授权许可】

   
2014 Wang et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C: Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990, 10:497-511.
• [2]Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature 2006, 444:881-887.
• [3]Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE, Manson JE: Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses’ Health Study. Am J Epidemiol 1997, 145:614-619.
• [4]Fox KA, Despres JP, Richard AJ, Brette S, Deanfield JE: Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91,246 ambulant patients in 27 European countries. Eur Heart J 2009, 30:3055-3063.
• [5]Carr MC, Brunzell JD: Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 2004, 89:2601-2607.
• [6]Despres JP: Is visceral obesity the cause of the metabolic syndrome? Ann Med 2006, 38:52-63.
• [7]Kissebah AH, Krakower GR: Regional adiposity and morbidity. Physiol Rev 1994, 74:761-811.
• [8]Bjorntorp P: Metabolic implications of body fat distribution. Diabetes Care 1991, 14:1132-1143.
• [9]Zhang X, Hu EA, Wu H, Malik V, Sun Q: Associations of leg fat accumulation with adiposity-related biological factors and risk of metabolic syndrome. Obesity (Silver Spring) 2013, 21:824-830.
• [10]Bruno E, Alessandrini M, Napolitano B, De Padova A, Di Daniele N, De Lorenzo A: Dual-energy X-ray absorptiometry analysis of body composition in patients affected by OSAS. Eur Arch Otorhinolaryngol 2009, 266:1285-1290.
• [11]Ben-Noun L, Sohar E, Laor A: Neck circumference as a simple screening measure for identifying overweight and obese patients. Obes Res 2001, 9:470-477.
• [12]Ben-Noun L, Laor A: Relationship of neck circumference to cardiovascular risk factors. Obes Res 2003, 11:226-231.
• [13]Zhou JY, Ge H, Zhu MF, Wang LJ, Chen L, Tan YZ, Chen YM, Zhu HL: Neck circumference as an independent predictive contributor to cardio-metabolic syndrome. Cardiovasc Diabetol 2013, 12:76. BioMed Central Full Text
• [14]LaBerge RC, Vaccani JP, Gow RM, Gaboury I, Hoey L, Katz SL: Inter- and intra-rater reliability of neck circumference measurements in children. Pediatr Pulmonol 2009, 44:64-69.
• [15]Koska J, Stefan N, Permana PA, Weyer C, Sonoda M, Bogardus C, Smith SR, Joanisse DR, Funahashi T, Krakoff J, Bunt JC: Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. Am J Clin Nutr 2008, 87:295-302.
• [16]Yoshimura E, Kumahara H, Tobina T, Matono S, Kiyonaga A, Kimura M, Tsukikawa H, Kono S, Etou T, Irie S, Anzai K, Tanaka H: Relationships between fat deposition in the liver and skeletal muscle and insulin sensitivity in Japanese individuals: a pilot study. Diabetes Metab Syndr Obes 2011, 4:35-43.
• [17]Laakso M, Matilainen V, Keinanen-Kiukaanniemi S: Association of neck circumference with insulin resistance-related factors. Int J Obes Relat Metab Disord 2002, 26:873-875.
• [18]Yang L, Samarasinghe YP, Kane P, Amiel SA, Aylwin SJ: Visceral adiposity is closely correlated with neck circumference and represents a significant indicator of insulin resistance in WHO grade III obesity. Clin Endocrinol (Oxf) 2010, 73:197-200.
• [19]Fang J, Alderman MH: Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. Jama 2000, 283:2404-2410.
• [20]Chien KL, Chen MF, Hsu HC, Chang WT, Su TC, Lee YT, Hu FB: Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem 2008, 54:310-316.
• [21]Heinig M, Johnson RJ: Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med 2006, 73:1059-1064.
• [22]Choi HK, Atkinson K, Karlson EW, Curhan G: Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005, 165:742-748.
• [23]Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T, Matsuzawa Y: Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 1998, 47:929-933.
• [24]Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Yamakita J, Higashino K: Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism 1997, 46:1162-1165.
• [25]Schusterova I, Leenen FH, Jurko A, Sabol F, Takacova J: Epicardial adipose tissue and cardiometabolic risk factors in overweight and obese children and adolescents. Pediatr Obes 2014, 9:63-70.
• [26]Marcus MA, Murphy L, Pi-Sunyer FX, Albu JB: Insulin sensitivity and serum triglyceride level in obese white and black women: relationship to visceral and truncal subcutaneous fat. Metabolism 1999, 48:194-199.
• [27]Shiina Y, Homma Y: Relationships between the visceral fat area on CT and coronary risk factor markers. Intern Med 2013, 52:1775-1780.
• [28]Wu H, Qi Q, Yu Z, Sun Q, Wang J, Franco OH, Sun L, Li H, Liu Y, Hu FB, Lin X: Independent and opposite associations of trunk and leg fat depots with adipokines, inflammatory markers, and metabolic syndrome in middle-aged and older Chinese men and women. J Clin Endocrinol Metab 2010, 95:4389-4398.
• [29]Sakai Y, Ito H, Egami Y, Ohoto N, Hijii C, Yanagawa M, Satoh S, Jingu S: Favourable association of leg fat with cardiovascular risk factors. J Intern Med 2005, 257:194-200.
• [30]Ben-Noun LL, Laor A: Relationship between changes in neck circumference and cardiovascular risk factors. Exp Clin Cardiol 2006, 11:14-20.
• [31]Fitch KV, Stanley TL, Looby SE, Rope AM, Grinspoon SK: Relationship between neck circumference and cardiometabolic parameters in HIV-infected and non-HIV-infected adults. Diabetes Care 2011, 34:1026-1031.
• [32]Preis SR, Massaro JM, Hoffmann U, D’Agostino RB Sr, Levy D, Robins SJ, Meigs JB, Vasan RS, O’Donnell CJ, Fox CS: Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab 2010, 95:3701-3710.
• [33]Preis SR, Pencina MJ, D’Agostino RB Sr, Meigs JB, Vasan RS, Fox CS: Neck circumference and the development of cardiovascular disease risk factors in the Framingham Heart Study. Diabetes Care 2013, 36:e3.
• [34]Wohl D, Scherzer R, Heymsfield S, Simberkoff M, Sidney S, Bacchetti P, Grunfeld C: The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men. J Acquir Immune Defic Syndr 2008, 48:44-52.
• [35]Eston RG, Rowlands AV, Charlesworth S, Davies A, Hoppitt T: Prediction of DXA-determined whole body fat from skinfolds: importance of including skinfolds from the thigh and calf in young, healthy men and women. Eur J Clin Nutr 2005, 59:695-702.
• [36]Onat A, Hergenc G, Yuksel H, Can G, Ayhan E, Kaya Z, Dursunoglu D: Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference. Clin Nutr 2009, 28:46-51.
• [37]Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudex C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
• [38]Back Giuliano Ide C, Caramelli B, Pellanda L, Duncan B, Mattos S, Fonseca FH: [I guidelines of prevention of atherosclerosis in childhood and adolescence]. Arq Bras Cardiol 2005, 85 Suppl 6:4-36.
• [39]Ryu KA, Kang HH, Kim SY, Yoo MK, Kim JS, Lee CH, Wie GA: Comparison of nutrient intake and diet quality between hyperuricemia subjects and controls in Korea. Clin Nutr Res 2014, 3:56-63.